GSK Critiques Anti-Counterfeiting Trade Agreement
Pharmaceutical giant GlaxoSmithKline has taken a stance on the Anti-Counterfeiting Trade Agreement (ACTA), welcoming most of its provisions, but requesting a harmonised approach for implementation, because the much-debated agreement would leave a lot of space for differing national implementations. GSK…
